imatinib mesylate has been researched along with Acute Biphenotypic Leukemia in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Davis, A; Gorniak, M; Grigoriadis, G; Ling, VY; Wall, M | 1 |
| Handa, H; Hatsumi, N; Nojima, Y; Sakura, T; Shimizu, H; Takada, S; Yokohama, A | 1 |
| Cai, P; Cao, XY; Fan, QZ; Liu, HX; Tong, CR; Wang, T; Wu, P; Wu, T; Zhang, X; Zhu, P | 1 |
| Berger, MG; Chabane, K; Hayette, S; Nicolini, FE; Tchirkov, A; Tournilhac, O | 1 |
| Borges, LF; Cahill, DP; Kahle, KT; Nahed, BV; Naunheim, MR; Soupir, CP; Walcott, BP | 1 |
| Broome, HE; Curtin, PT; Dell'Aquila, ML; Rashidi, HH; Thorson, JA; Wang, HY | 1 |
| Fujioka, T; Hosen, N; Ikegame, K; Kawakami, M; Kawase, I; Kim, EH; Konaka, Y; Kunitomi, A; Masuda, T; Mukouchi, C; Murakami, M; Nishida, S; Ogawa, H; Oji, Y; Oka, Y; Sugiyama, H; Taniguchi, Y; Tsuboi, A | 1 |
1 review(s) available for imatinib mesylate and Acute Biphenotypic Leukemia
| Article | Year |
|---|---|
Diagnosis of acute lymphoblastic leukemia from intracerebral hemorrhage and blast crisis. A case report and review of the literature.
Topics: Benzamides; Blast Crisis; Blood Cell Count; Diagnosis, Differential; Flow Cytometry; Humans; Imatinib Mesylate; In Situ Hybridization; Intracranial Hemorrhages; Leukemia, Biphenotypic, Acute; Leukocyte Count; Male; Middle Aged; Piperazines; Pyrimidines; Tomography, X-Ray Computed | 2010 |
6 other study(ies) available for imatinib mesylate and Acute Biphenotypic Leukemia
| Article | Year |
|---|---|
A dimorphic blast population demonstrates Philadelphia-positive mixed phenotype acute leukaemia.
Topics: Adult; Benzamides; Biopsy, Needle; Bone Marrow; Diagnosis, Differential; Female; Flow Cytometry; Granulocyte Precursor Cells; Humans; Imatinib Mesylate; In Situ Hybridization, Fluorescence; Induction Chemotherapy; Karyotyping; Leukemia, Biphenotypic, Acute; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Phenotype; Philadelphia Chromosome; Piperazines; Prognosis; Protein Kinase Inhibitors; Pyrimidines | 2014 |
Philadelphia chromosome-positive mixed phenotype acute leukemia in the imatinib era.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antigens, Surface; Antineoplastic Agents; Benzamides; Female; Humans; Imatinib Mesylate; Leukemia, Biphenotypic, Acute; Male; Middle Aged; Phenotype; Philadelphia Chromosome; Piperazines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein Kinase Inhibitors; Pyrimidines; Retrospective Studies; Treatment Outcome; Young Adult | 2014 |
[Major molecular response to imatinib in a patient with acute mixed lineage leukemia expressing a novel BCR/ABL transcript].
Topics: Adult; Benzamides; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Leukemia, Biphenotypic, Acute; Male; Piperazines; Pyrimidines | 2009 |
Detection of twelve nucleotides insertion in the BCR-ABL kinase domain in an imatinib-resistant but dasatinib-sensitive patient with bi-phenotypic acute leukemia.
Topics: Base Sequence; Benzamides; Dasatinib; Drug Resistance, Neoplasm; Female; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Leukemia, Biphenotypic, Acute; Middle Aged; Piperazines; Protein Kinase Inhibitors; Protein Structure, Tertiary; Protein-Tyrosine Kinases; Pyrimidines; Sequence Deletion; Thiazoles | 2009 |
t(4;22)(q12;q11.2) involving presumptive platelet-derived growth factor receptor A and break cluster region in a patient with mixed phenotype acute leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Benzamides; Chromosome Breakage; Chromosomes, Human, Pair 22; Chromosomes, Human, Pair 4; Cytarabine; Female; Flow Cytometry; Humans; Idarubicin; Imatinib Mesylate; Immunophenotyping; In Situ Hybridization, Fluorescence; Karyotype; Karyotyping; Leukemia, Biphenotypic, Acute; Middle Aged; Phenotype; Piperazines; Pyrimidines; Receptor, Platelet-Derived Growth Factor alpha; Remission Induction; Reverse Transcriptase Polymerase Chain Reaction; Translocation, Genetic | 2011 |
Successful treatment of bcr/abl-positive acute mixed lineage leukemia by unmanipulated bone marrow transplantation from an HLA-haploidentical (3-antigen-mismatched) cousin.
Topics: Adult; Antineoplastic Agents; Benzamides; Family; Female; Genes, abl; Graft vs Host Disease; Haplotypes; HLA Antigens; Humans; Imatinib Mesylate; Immunosuppressive Agents; Leukemia, Biphenotypic, Acute; Methotrexate; Methylprednisolone; Mycophenolic Acid; Pedigree; Piperazines; Pyrimidines; Tacrolimus; Tissue Donors; Transplantation, Homologous | 2003 |